Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor modulation of inflammatory response during human endotoxemia
NL-OMON42008Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ticagrelor (4 arms), sponsored by Radboud University Medical Center. Primary endpoint: Area under the curve of pro-inflammatory cytokines. Started Oct 2015; status: active, not recruiting.
02
Drugs
ticagrelor
Beyond the preview
Go deeper on NL-OMON42008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42008.